i-Base home
Search Menu
  • Home
  • HTB
  • 2019
  • May

May 2019

Contents

Editorial

  • HTB 20 May 2019: vol 20 no 6 – conference reports and PARTNER 2 published in The Lancet

Conference reports

  • 13th INTEREST workshop 14–17 May 2019, Accra, Ghana
  • No increased adverse outcomes among women starting dolutegravir before conception in the ADVANCE study
  • 25th Annual BHIVA Conference (BHIVA 2019)
  • Fifty new HIV diagnoses at Dean Street linked to caps on IMPACT study
  • Management of testosterone deficiency in HIV positive people
  • Importance of including menopause and bone health in management of HIV positive women
  • Type 2 diabetes is often undermanaged in HIV positive people
  • Adopting new US blood pressure targets for HIV positive people could reduce cardiovascular-related deaths
  • Selected webcasts from BHIVA 2019
  • Conference on Retroviruses and Opportunistic Infections (CROI 2019) 4–7 March, 2019
  • INSTI and weight gain: reports from CROI 2019
  • B/F/TAF suitable for children from six years of age

HIV prevention and transmission

  • PARTNER 2 study published in the Lancet: global news coverage that ART stops HIV transmission

PDFs

  • 20 May 2019 vol 20 no 6
  • HTB RSS

Early access

  • US CDC updated guidelines on PEP (May 2025) 10 May 2025
  • Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news 4 May 2025
  • The RIO study: Q&A about controlling HIV with bNAbs 21 April 2025
  • Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years 20 April 2025
  • All early access reports

Current issues

  • May 2025
  • April 2025
  • March 2025
  • Back issues

Special report

  • The Denver Principles – riso print by Jane Shepherd to support i-Base 17 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook